Providing excellence in clinical research delivery
Providing excellence in clinical research delivery
The National Institute for Health and Care Research (NIHR) Sheffield Clinical Research Facility (CRF) is part of the NIHR and hosted by Sheffield Teaching Hospitals NHS Foundation Trust in partnership with the University of Sheffield.
The NIHR funds, enables and delivers world-leading health and social care research that improves people’s health and wellbeing and promotes economic growth.
NIHR Clinical Research Facilities (CRFs) are purpose-built facilities in NHS hospitals where researchers can conduct studies. The NIHR has awarded £161 million over 5 years to 28 CRF facilities across England, to support early-phase and complex studies.
In 2022, the NIHR Sheffield CRF was awarded £7.9m in funding which will support the development and testing of new treatments for diseases, many of which currently have no cure. This funding award covers 2022 to 2029.
News & events
A woman who watched her own mother endure the debilitating effects of multiple sclerosis (MS) for more than 20 years and has recently been diagnosed with the disease herself said joining a new vaccine trial targeting a possible cause of the condition was an “obvious choice”.
Liz Hutchinson, 48, of Chesterfield, has become the first person in the region – and one of the first in the UK – to sign up to the Horizon trial at Sheffield Teaching Hospitals NHS Foundation Trust.
The groundbreaking trial, which is running in up to 10 sites in the UK including the Royal Hallamshire Hospital, is investigating whether an mRNA jab, designed to target Epstein-Barr virus (EBV), could offer a novel treatment pathway for the relapsing-remitting form of MS.
Researchers are exploring this avenue given that EBV, best known for causing glandular fever, is present in almost all individuals with MS and is believed to play a significant role in the condition’s development.
To read more, please visit the Sheffield Teaching Hospitals news page.
Site links